LOS ANGELES, Nov. 17, 2022 (GLOBE NEWSWIRE) -- Investor’s Business Daily (IBD), a leading financial news and research organization, released its special report on the best health savings accounts (HSAs) for 2023 this week. The report, IBD's sixth, provides comprehensive information on HSA rules and usage, and its list of the 13 Best HSA Accounts for 2023.

“Our 13 Best HSA Accounts for 2023 provides workers with essential information for evaluating health savings options,” said Susan Warfel, IBD’s managing editor. “We’re showcasing accounts with the best savings rates, low fees and wide investment options, no matter the size of their customer base—we’re debunking myths that confuse workers about how HSA accounts work.”

IBD reviewed reports from Devenir, Morningstar and individual HSA providers to select its 13 Best HSAs for 2023. IBD’s HSA list is geared toward educated consumers who have an interest in investing. Once IBD selected the top 13 account providers, it evaluated them based on five categories: widest investment options; low fees; best savings rates; zero investment threshold; and access to professional management. IBD’s list was finalized on Oct. 6, 2022. Savings rates were updated on Nov. 6, 2022.

Fidelity appears first in this list because it succeeded in every category award. Nine of the 13 providers on IBD's 2023 list won in one category or more.

• Fidelity Investments
• Optum Bank
• HSA Bank
• Liberty Federal Credit Union
• Saturna
• Lively
• Avidia
• Lake Michigan Credit Union
• First American Bank
• HealthEquity
• Bank of America
• UMB Healthcare
• Associated Bank
  

This year’s package also includes an overview detailing the current state of HSA saving and investing, a video highlighting IBD’s Best HSA recommendations and a story on 10 HSA misconceptions.

To learn all the latest news about HSAs, contribution levels for 2023 and changes in the HSA landscape, read IBD’s overview story: HSA Contributions Grew In 2023, Despite Rising Prices, Tough Investment Markets.

About Investor’s Business Daily
Investor’s Business Daily (IBD) is the leader in stock research and education. For over 35 years, IBD has helped countless investors around the world make more money in the market and achieve their financial goals. Founded with the mission of democratizing stock investing, IBD provides its customers access to the same type of research Wall Street uses to make decisions. All of IBD’s products and content are based on a time-tested investing methodology, which uses fundamental and technical analysis to identify leading stocks before their big price increases. IBD helps its customers succeed in the market with its unparalleled stock research including market-beating stock lists, proprietary stock ratings and powerful investing tools that help them make more profitable trading decisions. In addition, IBD provides customers with world-class investing education that includes product coaching, interactive webinars, live and virtual workshops, videos, online courses and more. IBD joined the Dow Jones and News Corp family of companies in May 2021. IBD reaches investors around the world via its main website, www.investors.com, its portfolio of digital products (IBD Digital, MarketSmith, Leaderboard, SwingTrader and IBD Live), mobile apps, a weekly print edition, social media and more. To learn more about all that IBD has available, please visit www.investors.com.

Press Contact:
Karen Lee
karenf.lee@dowjones.com